The relationship of the effective dose and safety of cinacalcet hydrochloride and etelcalcetide hydrochloride in the Japanese patients with secondary hyperparathyroidism receiving hemodialysis, when switching cinacalcet hydrochloride to etelcalcetide hydrochloride.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Etelcalcetide (Primary) ; Cinacalcet
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 05 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 21 Jun 2017 Status changed from not yet recruiting to recruiting.
- 06 Jun 2017 New trial record